The Contemporary Role of Beta Blockers in Patients With Acute Myocardial Infarction

Chongqing Medical University

Status: Unknown

Conditions: Acute Coronary Syndrome

Treatments: Drug: beta-blocker

Study type: Observational

Funder types: Other

Identifiers

NCT04564365

2020-09-22

Details and patient eligibility

About

The use of beta blockers after acute myocardial infarction is a core component of drug therapy, but evidence is primarily derived from patients who did not receive reperfusion therapy and secondary prophylaxis.In contemporary times, the prognostic value of beta blockers in patients with acute myocardial infarction has been questioned, particularly in patients without reduced heart failure/ejection fraction after acute myocardial infarction.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• The diagnosis of acute myocardial infarction was clear and the left ventricular ejection fraction was normal

Exclusion criteria

• History of heart failure Died in hospital

Trial design

1,000 participants in 2 patient groups

with beta-blocker

Treatment:

Drug: beta-blocker

without beta-blocker